China | New draft trade mark law strengthens brand protection
This article was first published on the IPHQ News website, 24 October 2025. China’s National Intellectual Property Administration (CNIPA) has proposed a new law aimed at strengthening trademark protection....
This article was first published on the IPHQ News website, 24 October 2025. China’s National Intellectual Property Administration (CNIPA)...
Read More
Australia | $5.8 million privacy penalty – a first for Privacy Law enforcement
A wake-up call for organisations required to comply with privacy laws, the Australian Federal Court’s $5.8 million penalty against Australian Clinical Labs Limited (ACL) marks the first civil penalty...
A wake-up call for organisations required to comply with privacy laws, the Australian Federal Court’s $5.8 million penalty against...
Read More
Indonesia | Understanding the annual Working Statement obligation
Comprehensive guide for patent holders on compliance with Indonesian Patent Law No. 65 of 2025 Indonesian Patent Law now requires all patent holders to file an annual statement of patent...
Comprehensive guide for patent holders on compliance with Indonesian Patent Law No. 65 of 2025 Indonesian Patent Law now requires...
Read More
The 2025 Pharmaceutical Patent Review
Welcome to Spruson & Ferguson’s review of the most notable developments in Australian pharmaceutical patent law in the past year. The year has seen a series of landmark decisions from...
Welcome to Spruson & Ferguson’s review of the most notable developments in Australian pharmaceutical patent law in the past...
Read More
Singapore | PPH Pilot offers partial refund for official fees
The Intellectual Property Office of Singapore (IPOS) has released a new initiative to support business entry into the Patent Prosecution Highway (PPH), with a pilot offering partial refund on...
The Intellectual Property Office of Singapore (IPOS) has released a new initiative to support business entry into the Patent...
Read More
Australia and New Zealand | Guide to differences in patent prosecution
A side-by-side look at patent prosecution in Australia and New Zealand While both jurisdictions share common roots, namely the Statute of Monopolies 1623, the Australia and New Zealand patent systems...
A side-by-side look at patent prosecution in Australia and New Zealand While both jurisdictions share common roots, namely the Statute...
Read More
Australia | Part 2: Regulatory considerations for orphan drugs
Following our first article on orphan drug development, which examined key patenting options and strategies, our second article sets out the key regulatory considerations in Australia. Orphan drug patent strategy...
Following our first article on orphan drug development, which examined key patenting options and strategies, our second article sets...
Read More
Australia | Part 1: Patenting orphan drugs
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical products developed to treat rare diseases, however with each drug...
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical...
Read More
China | Draft changes to dual filing in China
With double patenting prohibited in China, many applicants have utilised a dual filing strategy to secure patent rights, but this may be set to change. As noted in our article...
With double patenting prohibited in China, many applicants have utilised a dual filing strategy to secure patent rights, but...
Read More

Contact our Expert Team

Contact Us